FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; IBUPROFEN | 0573-0147-93 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-783-31 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-01 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-91 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-309-02 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 0143-9386-01 | Hikma Pharmaceuticals USA Inc. | NDA206968 | HUMAN PRESCRIPTION DRUG | NDA |
CAFFEINE; ASPIRIN; ACETAMINOPHEN | 69168-285-37 | Allegiant Health | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-95 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-04 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2040-06 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-77 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-08 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0143-9150-10 | Hikma Pharmaceuticals USA Inc. | NDA215320 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN | 51672-2114-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2117-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; CAFFEINE; ASPIRIN | 52904-871-50 | Select Corporation | NDA020802 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 72260-129-01 | AFT Pharmaceuticals Ltd | NDA209471 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN | 63323-434-00 | Fresenius Kabi USA, LLC | NDA204767 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 0067-8201-03 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE | 21695-143-72 | Rebel Distributors Corp. | NDA021123 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN; ASPIRIN; CAFFEINE | 66715-6549-2 | Lil' Drug Store Products, Inc. | NDA020802 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-36 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 50580-309-01 | Johnson & Johnson Consumer Inc. | NDA019872 | HUMAN OTC DRUG | NDA |
IBUPROFEN; ACETAMINOPHEN | 0573-0145-72 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 63323-434-41 | Fresenius Kabi USA, LLC | NDA204767 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-90 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN; IBUPROFEN | 0573-0147-09 | Haleon US Holdings LLC | NDA211733 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2117-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ASPIRIN; ACETAMINOPHEN; CAFFEINE | 0067-2039-84 | Haleon US Holdings LLC | NDA020802 | HUMAN OTC DRUG | NDA |
-